Other investigators have found that the frequent inactivation of the p14ARF and CDKN2A genes may be an important mechanism for the dysfunction of p53 and Rb growth regulatory pathways during bladder cancer development [31-34]. Here, CDKN2A is linked to urinary bladder cancer.